The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes
The previous edition of The Bethesda System for Reporting Thyroid Cytopathology provided important updates and advances in the practice of thyroid cytopathology. It was inspired by new developments in the field of thyroid cytopathology since the publication of the first edition in 2010. These included revised clinical guidelines for the management of patients with thyroid nodules, the introduction of molecular testing as an adjunct to cytopathologic examination, and the reclassification of the non-invasive follicular variant of papillary thyroid carcinoma as non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).

This new third edition provides updates to the current reporting terminology and diagnostic criteria, including new information on ancillary molecular testing, as well as imaging findings and clinical management. This book provides a more unified approach to diagnosing and reporting thyroid FNA interpretations. It simplifies the reporting structure by settling on just one name for each of the six categories and aligning terminology with the most recent classification of thyroid tumors by the World Health Organization.

Written by experts in the field, The Bethesda System for Reporting Thyroid Cytopathology, Third Edition aims to inspire advances in thyroid cytopathologic diagnosis and the betterment of patients with thyroid nodular disease. It serves as a reference guide not just for pathologists, but also endocrinologists, surgeons, and radiologists.


1120291191
The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes
The previous edition of The Bethesda System for Reporting Thyroid Cytopathology provided important updates and advances in the practice of thyroid cytopathology. It was inspired by new developments in the field of thyroid cytopathology since the publication of the first edition in 2010. These included revised clinical guidelines for the management of patients with thyroid nodules, the introduction of molecular testing as an adjunct to cytopathologic examination, and the reclassification of the non-invasive follicular variant of papillary thyroid carcinoma as non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).

This new third edition provides updates to the current reporting terminology and diagnostic criteria, including new information on ancillary molecular testing, as well as imaging findings and clinical management. This book provides a more unified approach to diagnosing and reporting thyroid FNA interpretations. It simplifies the reporting structure by settling on just one name for each of the six categories and aligning terminology with the most recent classification of thyroid tumors by the World Health Organization.

Written by experts in the field, The Bethesda System for Reporting Thyroid Cytopathology, Third Edition aims to inspire advances in thyroid cytopathologic diagnosis and the betterment of patients with thyroid nodular disease. It serves as a reference guide not just for pathologists, but also endocrinologists, surgeons, and radiologists.


79.99 In Stock
The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes

The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes

The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes

The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes

Paperback(3rd ed. 2023)

$79.99 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Related collections and offers


Overview

The previous edition of The Bethesda System for Reporting Thyroid Cytopathology provided important updates and advances in the practice of thyroid cytopathology. It was inspired by new developments in the field of thyroid cytopathology since the publication of the first edition in 2010. These included revised clinical guidelines for the management of patients with thyroid nodules, the introduction of molecular testing as an adjunct to cytopathologic examination, and the reclassification of the non-invasive follicular variant of papillary thyroid carcinoma as non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).

This new third edition provides updates to the current reporting terminology and diagnostic criteria, including new information on ancillary molecular testing, as well as imaging findings and clinical management. This book provides a more unified approach to diagnosing and reporting thyroid FNA interpretations. It simplifies the reporting structure by settling on just one name for each of the six categories and aligning terminology with the most recent classification of thyroid tumors by the World Health Organization.

Written by experts in the field, The Bethesda System for Reporting Thyroid Cytopathology, Third Edition aims to inspire advances in thyroid cytopathologic diagnosis and the betterment of patients with thyroid nodular disease. It serves as a reference guide not just for pathologists, but also endocrinologists, surgeons, and radiologists.



Product Details

ISBN-13: 9783031280450
Publisher: Springer International Publishing
Publication date: 06/30/2023
Edition description: 3rd ed. 2023
Pages: 290
Sales rank: 490,714
Product dimensions: 6.10(w) x 9.25(h) x (d)

About the Author

Syed Z. Ali, MD, FRCPath, FIAC
Professor of Pathology and Radiology
The Johns Hopkins Hospital
Baltimore, MD
USA

Paul A. VanderLaan MD, PhD
Associate Professor of Pathology
Beth Israel Deaconess Medical Center
Department of Pathology
Boston, MA
USA

Table of Contents

Table of Contents

The Bethesda System for Reporting Thyroid Cytopathology

Volume Editors: Syed Z. Ali, Edmund S. Cibas

1 Overview of Diagnostic Terminology and Reporting

Zubair W. Baloch

David S. Cooper

Hossein Gharib

Erik K. Alexander

2 Nondiagnostic/Unsatisfactory

Barbara A. Crothers

Michael R. Henry

Pinar Firat

Mary C. Frates

Esther Diana Rossi

3 Benign

Tarik M. Elsheikh

Béatrix Cochand-Priollet

Soon-Won Hong

Mary K. Sidawy

4 Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance

Jeffrey F. Krane

Ritu Nayar

Andrew A. Renshaw

5 Follicular Neoplasm/Suspicious for a Follicular Neoplasm

Michael R. Henry

William H. Westra

Jeffrey F. Krane

Fernando Schmitt

6 Follicular Neoplasm, Hürthle Cell (Oncocytic) Type/Suspicious for a Follicular Neoplasm, Hürthle Cell (Oncocytic) Type

William C. Faquin

Claire W. Michael

Andrew A. Renshaw

Philippe Vielh

7 Suspicious for Malignancy

Paul A. VanderLaan

Ashish Chandra

Armando C. Filie

Gregory W. Randolph

Celeste N. Powers

8 Papillary Thyroid Carcinoma, Variants, and Related Tumors

Marc P. Pusztaszeri

Manon Auger

Edward B. Stelow

Grace C. H. Yang

Miguel A. Sanchez

Virginia A. Livolsi

9 Medullary Thyroid Carcinoma

Michiya Nishino

Marc P. Pusztaszeri

Martha Bishop Pitman

10 Poorly Differentiated Thyroid Carcinoma

Massimo Bongiovanni

Guido Fadda

William C. Faquin

11 Undifferentiated (Anaplastic) Carcinoma and Squamous Cell Carcinoma of the Thyroid

Gregg A. Staerkel

Justin A. Bishop

Vinod B. Shidham

Matthew A. Zarka

12 Metastatic Tumors, Lymphomas, and Rare Tumors of the Thyroid

Lester J. Layfield

Kennichi Kakudo

 

From the B&N Reads Blog

Customer Reviews